The aim of this study was to investigate whether treatment with rapamycin plus vildagliptin restores beta-cell function in patients with long-standing type 1 diabetes.
Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial / Bolla, Andrea Mario; Gandolfi, Alessandra; Borgonovo, Elisa; Laurenzi, Andrea; Caretto, Amelia; Molinari, Chiara; Catalano, Roberta Sara; Bianconi, Eleonora; Monti, Paolo; Sordi, Valeria; Pellegrini, Silvia; Lampasona, Vito; Costa, Sabrina; Scavini, Marina; Bosi, Emanuele; Piemonti, Lorenzo. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 106:2(2021), pp. 507-519. [10.1210/clinem/dgaa791]
Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial
Borgonovo, Elisa;Laurenzi, Andrea;Bosi, EmanuelePenultimo
;Piemonti, Lorenzo
Ultimo
2021-01-01
Abstract
The aim of this study was to investigate whether treatment with rapamycin plus vildagliptin restores beta-cell function in patients with long-standing type 1 diabetes.| File | Dimensione | Formato | |
|---|---|---|---|
|
dgaa791.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Copyright dell'editore
Dimensione
3.12 MB
Formato
Adobe PDF
|
3.12 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
